The emergence of photodynamic therapy as a major modality in cancer treatment

Reviews in Contemporary Pharmacotherapy

Volumn 10, Issue 1, 1999, Pages 69-74

  Hahn, Stephen M ^a   Glatstein, Eli ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOSENSITIZING AGENT;

ADVANCED CANCER; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOMA IN SITU; DOSIMETRY; INTERMETHOD COMPARISON; PHOTODYNAMIC THERAPY; PRECANCER; REVIEW; SOLID TUMOR;

EID: 0032914537     PISSN: 09548602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Bagshaw MA, Kaplan ID, Cox RC. Prostate cancer. Radiation therapy for localized disease. Cancer 1993; 71 (Suppl 3): 939-952.
2. Barr H, Shepherd NA, Dix A, Roberts DJH, Tan WC, Krasner N. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996; 348: 584-585.
3. Catalona WJ, Smith DS. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 1994; 152: 1837-1842.
4. Chen Q, Wilson BC, Shetty SD, Patterson MS, Cerny JC, Hetzel FW. Changes in in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy. Radiat Res 1997; 147: 86-91.
5. D'Amico AV, Coleman CN. Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer the jury is still out. J Clin Oncol 1996; 14: 304-315.
6. Delaney TF, Sindelar WF, Tochner Z et al. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumours. Int J Radial Oncol Biol Phys 1993; 25: 445-457.
7. Dillman RO, Seagren SL, Propert KJ et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 1990; 323: 940-945.
8. Dougherty TJ, Cooper MT, Mang TS. Cutaneous phototoxic occurrences in patients receiving Photofrin. Lasers Surg Med 1990; 10: 485-488.
9. Dougherty TJ, Corner DJ, Henderson BW et al. Photodynamic therapy. J Natl Cancer Inst 1998; 90: 889-905.
10. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339: 1-15.
11. Farrell TJ, Wilson BC, Patterson MS, Olivo MC. Comparison of the in vivo photodynamic threshold dose for photofrin, mono- and tetrasulfonated aluminum phthalocyanine using a rat liver model. Photochem Photobiol 1998; 68: 394-399.
12. Geyer C, Papadimhrakopoulou V, Hong WK. Chemoprevention in head and neck cancer: basic science and clinical application. Semin Radiat Oncol 1998; 8: 292-301.
13. 14C]-hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res 1979; 39: 146-151.
14. Grant WE, Hopper C, Speight PM, MacRobert AJ, Bown SG. Photodynamic therapy of malignant and premalignant lesions in patients with 'field cancerization' of the oral cavity. J Laryngol Otol 1993; 107: 1140-1145.
15. Gutin PH, Leibel SA, Hosobuchi Y et al. Brachytherapy of recurrent tumors of the skull base and spine with iodine-125 sources. Neurosurgery 1987; 20: 938-945.
16. Herscher LL, Hahn SM, Kroog G et al. Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small cell lung cancer. J Clin Oncol 1998; 16: 635-641.
17. Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for Stage III non-small-cell lung cancer: a randomized trial. J Clin Oncol 1996; 14: 1065-1070.
18. Jori G. Tumour photosensitizers: approaches to enhanced selectivity and efficiency of photodynamic therapy. J Photochem Photobiol B-Biol 1996; 36: 87-93.
19. Lightdale CJ, Heier SK, Marcon NE et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd-YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc 1995; 42: 507-512.
20. Mattson K, Holsti LR, Tammilehto L et al. Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemilhorax irradiation. Int J Radiat Oncol Biol Phys 1992; 24: 643-650.
21. Moghissi K, Dixon K, Parsons RJ. A controlled trial of Nd-YAG laser vs photodynamic therapy for advanced malignant bronchial obstruction. Lasers Med Sci 1993; 8: 269-273.
22. Mullooly VM, Abramson AL, Shikowitz MJ. Dihematoporphyrin ether-induced photosensitivity in laryngeal papilloma patients. Lasers Surg Med 1990; 10: 349-356.
23. Nseyo UO, Shumaker B, Klein EA, Sutherland K. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group. J Urol 1998; 160: 39-44.
24. Overholt BF, Panjehpour M. Photodynamic therapy in Barren's esophagus. J Clin Laser Med Surg 1996; 14: 245-249.
25. Palley SL, Sampliner RE, Garewal HS. Management of high-grade dysplasia in Barren's esophagus. J Clin Gastroenterol 1989; 11: 369-372.
26. Panella TJ, Wieman TJ, Dougherty S et al. Lutetium texaphyrin (Lu-Tex) photodynamic therapy (PDT) of patients with refractory locally recurrent breast cancer. Proc Am Soc Clin Oncol 1998; 17: 165.
27. Pass HI, Donington JS. Use of photodynamic therapy for the management of pleural malignancies. Semin Surg Oncol 1995; 11: 360-367.
28. Sindelar WF, Sullivan FJ, Abraham E et al. Intraperitoneal photodynamic therapy shows efficacy in Phase I trial. Proc Annu Meet Am Soc Clin Oncol 1995; 14: A1550.
29. Spechler JS. Barren's esophagus. Semin Oncol 1994; 21: 431-437.
30. Star WM. Light dosimetry in vivo. Phys Med Biol 1997; 42: 763-787.
31. Takita H, Mang TS, Loewen GM et al. Operation and intracavitary photodynamic therapy for malignant pleural mesothelioma: a phase II study. Ann Thorac Surg 1994; 58: 995-998
32. Wagnieres G, Hadjur C, Grosjean P et al. Clinical evaluation of the cutaneous phototoxicity of 5,10,15,20-tetra (m-hydroxyphenyl) chlorin. Photochem Photobiol 1998; 68: 382-387.
33. Young SW, Woodburn KW, Wright M et al. Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer. Photochem Photobiol 1996; 63: 892-897.